238
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

MicroRNA Let-7i Regulates Innate TLR4 Pathways in Peripheral Blood Mononuclear Cells of Patients with Ankylosing Spondylitis

, , , , , & show all
Pages 1393-1401 | Received 18 Nov 2022, Accepted 11 Apr 2023, Published online: 19 Apr 2023

References

  • Brown MA, Kenna T, Wordsworth BP. Genetics of ankylosing spondylitis--insights into pathogenesis. Nat Rev Rheumatol. 2016;12(2):81–91. doi:10.1038/nrrheum.2015.133
  • Simone D, Al Mossawi MH, Bowness P. Progress in our understanding of the pathogenesis of ankylosing spondylitis. Rheumatology. 2018;57(suppl_6):vi4–vi9. doi:10.1093/rheumatology/key001
  • Bond D. Ankylosing spondylitis: diagnosis and management. Nurs Stand. 2013;28(16–18):52–9; quiz 60. doi:10.7748/ns2013.12.28.16.52.e7807
  • Smith JA. Update on ankylosing spondylitis: current concepts in pathogenesis. Curr Allergy Asthma Rep. 2015;15(1):489. doi:10.1007/s11882-014-0489-6
  • Babaie F, Hasankhani M, Mohammadi H, et al. The role of gut microbiota and IL-23/IL-17 pathway in ankylosing spondylitis immunopathogenesis: new insights and updates. Immunol Lett. 2018;196:52–62. doi:10.1016/j.imlet.2018.01.014
  • Jethwa H, Bowness P. The interleukin (IL)-23/IL-17 axis in ankylosing spondylitis: new advances and potentials for treatment. Clin Exp Immunol. 2016;183(1):30–36. doi:10.1111/cei.12670
  • Michonneau D, Latis E, Curis E, et al. Metabolomics analysis of human acute graft-versus-host disease reveals changes in host and microbiota-derived metabolites. Nat Commun. 2019;10(1):5695. doi:10.1038/s41467-019-13498-3
  • Koupenova M, Clancy L, Corkrey HA, Freedman JE. Circulating Platelets as Mediators of Immunity, Inflammation, and Thrombosis. Circ Res. 2018;122(2):337–351. doi:10.1161/circresaha.117.310795
  • Oliveira-Toré CF, Moraes AG, Martinez GF, et al. Genetic polymorphisms of toll-like receptors 2 and 9 as susceptibility factors for the development of ankylosing spondylitis and psoriatic arthritis. J Immunol Res. 2019;2019:1492092. doi:10.1155/2019/1492092
  • Aletaha S, Haddad L, Roozbehkia M, et al. M2000 (β-D-Mannuronic Acid) as a novel antagonist for blocking the TLR2 and TLR4 downstream signalling pathway. Scand J Immunol. 2017;85(2):122–129. doi:10.1111/sji.12519
  • Mitchell S, Mercado EL, Adelaja A, et al. An NFκB activity calculator to delineate signaling crosstalk: type I and II interferons enhance NFκB via distinct mechanisms. Front Immunol. 2019;10:1425. doi:10.3389/fimmu.2019.01425
  • Li M, He Y, Zhou Z, et al. MicroRNA-223 ameliorates alcoholic liver injury by inhibiting the IL-6-p47(phox)-oxidative stress pathway in neutrophils. Gut. 2017;66(4):705–715. doi:10.1136/gutjnl-2016-311861
  • Schildberg FA, Klein SR, Freeman GJ, Sharpe AH. Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family. Immunity. 2016;44(5):955–972. doi:10.1016/j.immuni.2016.05.002
  • Pauley KM, Chan EK. MicroRNAs and their emerging roles in immunology. Ann N Y Acad Sci. 2008;1143:226–239. doi:10.1196/annals.1443.009
  • Reyes-Loyola P, Rodríguez-Henríquez P, Ballinas-Verdugo MA, et al. Plasma let-7i, miR-16, and miR-221 levels as candidate biomarkers for the assessment of ankylosing spondylitis in Mexican patients naïve to anti-TNF therapy. Clin Rheumatol. 2019;38(5):1367–1373. doi:10.1007/s10067-019-04509-1
  • Najm A, Blanchard F, Le Goff B. Micro-RNAs in inflammatory arthritis: from physiopathology to diagnosis, prognosis and therapeutic opportunities. Biochem Pharmacol. 2019;165:134–144. doi:10.1016/j.bcp.2019.02.031
  • Li Z, Wong SH, Shen J, Chan MTV, Wu WKK. The role of MicroRNAS in ankylosing spondylitis. Medicine. 2016;95(14):e3325. doi:10.1097/md.0000000000003325
  • Yang W, Yan X, Xia Q, et al. Predisposition of six well-characterized microRNAs to syndesmophytes among Chinese patients with ankylosing spondylitis. Mod Rheumatol. 2019;29(1):173–180. doi:10.1080/14397595.2018.1453277
  • Zochling J. Measures of symptoms and disease status in ankylosing spondylitis: Ankylosing Spondylitis Disease Activity Score (ASDAS), Ankylosing Spondylitis Quality of Life Scale (ASQoL), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing Spondylitis Global Score (BAS-G), Bath Ankylosing Spondylitis Metrology Index (BASMI), Dougados Functional Index (DFI), and Health Assessment Questionnaire for the Spondylarthropathies (HAQ-S). Arthritis Care Res. 2011;63(Suppl 11):S47–58. doi:10.1002/acr.20575
  • Cui H, Xie N, Tan Z, et al. The human long noncoding RNA lnc-IL7R regulates the inflammatory response. Eur J Immunol. 2014;44(7):2085–2095. doi:10.1002/eji.201344126
  • Coronnello C, Benos PV. ComiR: combinatorial microRNA target prediction tool. Nucleic Acids Res. 2013;41(WebServer issue):W159–W164. doi:10.1093/nar/gkt379
  • Vanaki N, Aslani S, Jamshidi A, Mahmoudi M. Role of innate immune system in the pathogenesis of ankylosing spondylitis. Biomed Pharmacother. 2018;105:130–143. doi:10.1016/j.biopha.2018.05.097
  • Nahid MA, Satoh M, Chan EK. MicroRNA in TLR signaling and endotoxin tolerance. Cell Mol Immunol. 2011;8(5):388–403. doi:10.1038/cmi.2011.26
  • Kragstrup TW, Andersen T, Holm C, et al. Toll-like receptor 2 and 4 induced interleukin-19 dampens immune reactions and associates inversely with spondyloarthritis disease activity. Clin Exp Immunol. 2015;180(2):233–242. doi:10.1111/cei.12577
  • Wang H, Sun N, Li K, Tian J, Li J. Assay of peripheral regulatory Vδ1 T cells in ankylosing spondylitis and its significance. Med Sci Monit. 2016;22:3163–3168. doi:10.12659/msm.897126
  • Detassis S, Grasso M, Del Vescovo V, Denti MA. microRNAs make the call in cancer personalized medicine. Front Cell Dev Biol. 2017;5:86. doi:10.3389/fcell.2017.00086
  • Janský L, Reymanová P, Kopecký J. Dynamics of cytokine production in human peripheral blood mononuclear cells stimulated by LPS or infected by Borrelia. Physiol Res. 2003;52(6):593–598.